Jeff Auxier's GILD Position Overview
Jeff Auxier (via Auxier Asset Management LLC) currently holds 8,993 shares of Gilead Sciences, Inc. (GILD) worth $998,223, representing 0.14% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Jeff Auxier has maintained a strategic position in GILD, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2020, adding 3,703 shares. Largest reduction occurred in Q4 2024, reducing 2,072 shares.
Analysis based on 13F filings available since 2013 Q2
Jeff Auxier's Gilead Sciences (GILD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Gilead Sciences (GILD) Trades by Jeff Auxier
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2015 | +2,282 | New Buy | 2,282 | $101.23 |
| Q1 2016 | +700 | Add 30.67% | 2,982 | $91.88 |
| Q3 2016 | +1,800 | Add 60.36% | 4,782 | $79.05 |
| Q4 2016 | +695 | Add 14.53% | 5,477 | $71.57 |
| Q1 2017 | +1,200 | Add 21.91% | 6,677 | $67.99 |
| Q2 2017 | +96 | Add 1.44% | 6,773 | $70.72 |
| Q3 2017 | +1,357 | Add 20.04% | 8,130 | $81.06 |
| Q4 2017 | +150 | Add 1.85% | 8,280 | $71.62 |
| Q1 2018 | +95 | Add 1.15% | 8,375 | $75.34 |
| Q2 2018 | +100 | Add 1.19% | 8,475 | $70.80 |
| Q3 2018 | +3,075 | Add 36.28% | 11,550 | $77.23 |
| Q4 2018 | -1,345 | Reduce 11.65% | 10,205 | $62.52 |
| Q1 2019 | +1,625 | Add 15.92% | 11,830 | $65.00 |
| Q2 2019 | -1,780 | Reduce 15.05% | 10,050 | $67.56 |
| Q4 2019 | -100 | Reduce 1.00% | 9,950 | $65.03 |
| Q1 2020 | +1,850 | Add 18.59% | 11,800 | $74.75 |
| Q2 2020 | -50 | Reduce 0.42% | 11,750 | $76.94 |
| Q3 2020 | +3,703 | Add 31.51% | 15,453 | $63.16 |
| Q4 2020 | -1,355 | Reduce 8.77% | 14,098 | $58.24 |
| Q2 2021 | -150 | Reduce 1.06% | 13,948 | $68.83 |
| Q4 2021 | -490 | Reduce 3.51% | 13,458 | $72.60 |
| Q1 2022 | -150 | Reduce 1.11% | 13,308 | $59.44 |
| Q3 2022 | -70 | Reduce 0.53% | 13,238 | $61.72 |
| Q4 2022 | -30 | Reduce 0.23% | 13,208 | $85.85 |
| Q1 2023 | -370 | Reduce 2.80% | 12,838 | $82.97 |
| Q2 2023 | -35 | Reduce 0.27% | 12,803 | $77.07 |
| Q3 2023 | -220 | Reduce 1.72% | 12,583 | $74.94 |
| Q4 2023 | -366 | Reduce 2.91% | 12,217 | $81.01 |
| Q1 2024 | -382 | Reduce 3.13% | 11,835 | $73.25 |
| Q2 2024 | -10 | Reduce 0.08% | 11,825 | $68.61 |
| Q3 2024 | -48 | Reduce 0.41% | 11,777 | $83.84 |
| Q4 2024 | -2,072 | Reduce 17.59% | 9,705 | $92.37 |
| Q1 2025 | -507 | Reduce 5.22% | 9,198 | $112.05 |
| Q2 2025 | -45 | Reduce 0.49% | 9,153 | $110.87 |
| Q3 2025 | -160 | Reduce 1.75% | 8,993 | $111.00 |
Jeff Auxier's Gilead Sciences Investment FAQs
Jeff Auxier first purchased Gilead Sciences, Inc. (GILD) in Q4 2015, acquiring 2,282 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier has held Gilead Sciences, Inc. (GILD) for 40 quarters since Q4 2015.
Jeff Auxier's largest addition to Gilead Sciences, Inc. (GILD) was in Q3 2020, adding 15,453 shares worth $976,000.
According to the latest 13F filing for Q3 2025, Jeff Auxier's firm, Auxier Asset Management LLC, owns 8,993 shares of Gilead Sciences, Inc. (GILD), valued at approximately $998,223.
As of the Q3 2025 filing, Gilead Sciences, Inc. (GILD) represents approximately 0.14% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings.
Jeff Auxier's peak holding in Gilead Sciences, Inc. (GILD) was 15,453 shares, as reported at the end of Q3 2020.